Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study

Status: Recruiting
Location: See all (4) locations...
Study Type: Observational
SUMMARY

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of renal failure. For several decades, ADPKD was regarded as an adult-onset disease. In the last decade, it has become more widely appreciated that the disease course begins in childhood. However, evidence-based guidelines on how to manage and approach children diagnosed with or at-risk for of ADPKD are lacking. Overall, there is insufficient data on the clinical course during childhood. The study intends to get more information on Autosomal Dominant Polycystic Kidney Disease (ADPKD) and other hepato/renal fibrocystic diseases. Additionally, the study intends to expand web-based resources so anyone can learn about ADPKD or other hepato/renal fibrocystic diseases. Individuals diagnosed with the dominant form of a hepato/renal fibrocystic condition are invited to be in the study.

Eligibility
Participation Requirements
Sex: All
Maximum Age: 18
Healthy Volunteers: f
View:

• Demonstration of ADPKD by clinical information, imaging studies, biopsy, autopsy, or genetic testing.

Locations
United States
Washington, D.c.
Children's National Hospital
RECRUITING
Washington D.c.
Minnesota
Mayo Clinic
RECRUITING
Rochester
New York
Cohen Children's Medical Center
ENROLLING_BY_INVITATION
New Hyde Park
Pennsylvania
Children's Hospital of Philadelphia
RECRUITING
Philadelphia
Contact Information
Primary
Jasmine Jaber, MS
jaberj2@chop.edu
267-425-5325
Time Frame
Start Date: 2019-10-10
Estimated Completion Date: 2030-10-30
Participants
Target number of participants: 300
Sponsors
Leads: Children's Hospital of Philadelphia
Collaborators: National Institutes of Health (NIH)

This content was sourced from clinicaltrials.gov